allodynia from tirzepatide In four recent placebo-controlled clinical trials, dysesthesia, an unpleasant sensation that's perceived on or under the skin, was reported as a side effect of the GLP-1 agonist semaglutide in 5-23% of recipients Allodynia: What It Is, Causes,

For researchers following tirzepatide microdosing protocols with smaller, more frequent doses, vial longevity becomes an even bigger concern

Cellular reprogramming is the process by which somatic cells can be converted to a pluripotent state

Synthesis and structure-activity relationships of neuromuscular blocking agents

These benefits primarily derived from improved glucose control, weight reduction, enhanced cardiac output, and lower blood pressure

A 2024 systematic review found some positive results (66.7% of studies reported positive impact), but methodological issues in those studies (small sample sizes, lack of biochemical validation, poor randomization) make it hard to draw firm conclusions

Without baseline values, you have no reference point to assess whether tirzepatide is helping, hurting, or doing nothing